Successful treatment with linezolid of septic shock secondary to methicillin-resistant Staphylococcus aureus arthritis [4]

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 5, 2005, Pages 812-813

  De Bels, David ^a   Garcia Filoso, A ^a   Jeanmaire, M ^a   Preseau T ^a   Miendje, Y ^a   Devriendt, J ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

MRSA; Oxazolidinones; Septic arthritis

Indexed keywords

ACTIVATED PROTEIN C; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LINEZOLID; METICILLIN; OXACILLIN; VANCOMYCIN;

ACUTE KIDNEY FAILURE; AGED; ANTIBIOTIC SENSITIVITY; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; BLOOD CULTURE; CASE REPORT; CLINICAL EXAMINATION; DRUG BLOOD LEVEL; EDEMA; FEVER; HEART ARREST; HEART CATHETERIZATION; HEMATOLOGIC DISEASE; HEMOFILTRATION; HOSPITAL DISCHARGE; HUMAN; HYPOVOLEMIA; INFECTIOUS ARTHRITIS; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PUNCTURE; PUS; RESUSCITATION; SEPTIC SHOCK; SHOULDER PAIN; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VASODILATATION;

ACETAMIDES; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ARTHRITIS, INFECTIOUS; HUMANS; MALE; METHICILLIN RESISTANCE; OXAZOLIDINONES; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 18844405246     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki068     Document Type: Letter

References (6)

1. Livermore, D. M. (2003). Linezolid in vitro: mechanism and antimicrobial spectrum. Journal of Antimicrobial Chemotherapy 51, Suppl. S2, 9-16.
2. Kraft, M. D., Pasko, D. A., DePestel, D. D. et al. (2003). Linezolid clearance during continuous venovenous hemodiafiltration: a case report. Pharmacotherapy 23, 1071-5.
3. Levine, D. P., Fromm, B. S. & Reddy, B. R. (1991). Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Annals of Internal Medicine 115, 674-80.
4. Kutscha-Lissberg, F., Hebler, U., Muhr, G. et al. (2003). Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy 47, 3964-6.
5. Cepeda, J. A., Whitehouse, T., Cooper, B. et al. (2004). Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study. Journal of Antimicrobial Chemotherapy 53, 345 -55.
6. Gerson, S. L., Kaplan, S. L., Bruss, J. B. et al. (2002), Hematologic effects of linezolid: summary of clinical experience. Antimicrobial Agents and Chemotherapy 46, 2723-6.